Apports des analogues de la LHRH dans le traitement du cancer de la prostate

M. Zerbib, en collaboration avec A. Descazeaud
{"title":"Apports des analogues de la LHRH dans le traitement du cancer de la prostate","authors":"M. Zerbib,&nbsp;en collaboration avec A. Descazeaud","doi":"10.1016/S0003-4401(07)80516-X","DOIUrl":null,"url":null,"abstract":"<div><p>The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)80516-X","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales D Urologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000344010780516X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The contribution of LHRH analogs is enormous in prostate cancer management at nearly all stages of the disease, the leading cancer in males over 50 years of age. They make it possible to use hormone therapy reliably, with little morbidity, and can be reversed. Their use can be immediate or delayed, continuous or intermittent, whether or not they are associated with an antiandrogen, and can be associated with chemotherapy for patients who have reached the stage of hormone-refractory prostate cancer.

LHRH类似物在前列腺癌治疗中的作用
前列腺癌是50岁以上男性的主要癌症,LHRH类似物在前列腺癌的几乎所有阶段的治疗中都有巨大的贡献。它们使使用激素治疗变得可靠,发病率低,并且可以逆转。它们的使用可立即或延迟,连续或间歇,无论它们是否与抗雄激素相关,并且可与已达到激素难治性前列腺癌阶段的患者的化疗相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annales D Urologie
Annales D Urologie 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信